Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples